Julie Lamb, Editor

About the Author Julie Lamb, Editor

Julie joined Smarter Analyst across the world- all the way from Louisville, Kentucky- where she graduated with a Bachelor of Arts in English with a focus on creative writing from the University of Louisville.

Apple Inc. (AAPL): Attractive Risk/Reward Ahead of Earnings, Says Piper Jaffray

Piper Jaffray analyst Michael Olson previews Apple Inc. (NASDAQ:AAPL) ahead of its first fiscal quarter …

Read more

3 Reasons to Sell Tesla Motors Inc (TSLA)

Is Tesla Motors Inc (NASDAQ:TSLA) stock veering dangerously toward an overrated status and value? Is CEO …

Read more

A Glimpse into the Mast Therapeutics Inc (MSTX) and Savara Merger

Mast Therapeutics Inc (NYSEMKT:MSTX) and Savara, a privately held pharmaceutical firm aimed at treating rare …

Read more

Analysts Highlights Apple Inc. and Alibaba Group Holding Ltd as Stocks to Buy

Analysts are offering bullish views on Apple Inc. (NASDAQ:AAPL) and Alibaba Group Holding Ltd (NYSE:BABA), …

Read more

Northland Sidelined On Rex Energy Corporation (REXX) Despite Better-Than-Expected Guidance

Rex Energy Corporation (NASDAQ:REXX) shares have fallen back 9% after seeing a sharp 17% rise …

Read more

Needham Divided On Two Biotech Players: Gilead Sciences, Inc. (GILD), ACADIA Pharmaceuticals Inc. (ACAD)

Needham analyst Alan Carr is out with a mixed research report today on biotech players …

Read more

Friday’s Market Insights: Interpace Diagnostics Group Inc (IDXG), Skyworks Solutions Inc (SWKS), and Bellerophon Therapeutics Inc (BLPH)

The following three stocks are climbing today: Interpace Diagnostics Group Inc (NASDAQ:IDXG), Skyworks Solutions Inc …

Read more

Synergy Pharmaceuticals Inc (SGYP) Shares Fall on Back of ‘Sell on the News’ Reaction; Rodman & Renshaw Bullish

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) impressed Rodman & Renshaw analyst Ram Selvaraju with the announcement yesterday …

Read more

Gene Munster’s First Call on Apple Inc. (AAPL): Expects Strong FQ1 Print

Former Piper Jaffray top analyst Gene Munster is back with a confident call on Apple …

Read more

William Blair Bullish on Synthetic Biologics Inc (SYN) on Back of FDA Phase IIb/III Trial Design Approval

Synthetic Biologics Inc (NYSEMKT:SYN) revealed Wednesday, January 18th after market close that the FDA has …

Read more